生产企业：Corcept Therapeutics
Relacorilant is under investigation in clinical trial NCT02804750 (Study to Evaluate CORT125134 in Patients With Cushing's Syndrome).
Relacorilant is under investigation in clinical trial NCT02804750 (Study to Evaluate CORT125134 in Patients With Cushing's Syndrome).
Relacorilant is a selective glucocorticoid receptor modulator (glucocorticoid receptor antagonist) that binds to the glucocorticoid receptor without binding to the body's other hormone receptors.
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
